José Luis Fernández-Luna
Head of the Cell Signalling and Therapeutic Targets in Cancer research group at IDIVAL.
He has been a Research Associate at the Washington University School of Medicine in St. Louis and a member of the board of directors of the Biomedicine Division.
He is a member of the board of directors of the Spanish Association for Cancer Research. With 30 years of experience, he has more than 100 international publications and a high rating of scientific excellence, with more than 10,000 citations to his papers and an h-index of 43.
Photometry and Radiometry Division
Professor at the University of Cantabria, PhD in Science and Co-Director of the Optics Group at the University of Cantabria. He has been Visiting Research Professor at UC San Diego.
In 2010 he was named Senior Member of the Optical Society of America (OSA), a recognition for his experience and professional achievements in the field of optics and photonics and where the 162 best scientists from all over the world are listed.
In his more than 35 years of experience he has accumulated more than 100 international research publications.
PhD in and professor at the University of Cantabria. Co-director of the Optics Group at the UC. With more than 40 years of experience, he is co-author of more than 150 articles, 200 conference papers and 6 patents.
For more than twenty years he has been collaborating with researchers from international centres, such as the Fresnel Institute in Marseille (France), CNR - NANOTEC, Bari (Italy), Duke University (USA) and the Army Research Laboratory (Maryland, USA).
He has participated as principal investigator or collaborating researcher in more than 27 competitive projects (6 of international scope, funded by the Royal Society of London and the US Army) and 20 projects with private companies.
Verónica Vidal Sánchez
R & D
PhD in Molecular Biology and Biomedicine
She has done postdoctoral work in Neurobiology of Learning at the University of Cantabria.
She has also worked in the Cell Signalling and Therapeutic Targets in Cancer group at the Valdecilla Institute for Health Research (IDIVAL).